Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04) [Phase 1, Phase 2]
This is a Clinical Trial Update for KEYMAKER-U04, a Phase 1/2 study evaluating new treatments given with enfortumab vedotin and pembrolizuma…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies [Phase 1]
This Phase 1 clinical trial update evaluates Bintrafusp alfa (M7824) and PDS01ADC alone and in combination with SBRT in adults with metastat…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluation for NCI Surgery Branch Clinical Research Protocols
NCI's Surgery Branch Clinical Research Protocols are currently recruiting for multiple cancer studies, including synovial sarcoma, melanoma,…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) [Phase 3]
This document announces a Phase 3 clinical trial (MK-2870-031) evaluating sacituzumab tirumotecan for bladder/urothelial cancer, which is cu…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
The document announces the recruitment status for a clinical evaluation of BCDx to monitor recurrence in non-muscle invasive bladder cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy [NA]
A clinical trial is evaluating acupuncture and exercise to manage peripheral neuropathy caused by enfortumab vedotin plus pembrolizumab in p…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) [Phase 1, Phase 2]
An update on the clinical study MK-3120-003 in bladder cancer, indicating the trial is currently recruiting for Phase 1 and Phase 2.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors [Phase 1]
BeiGene is conducting a Phase 1 safety study to evaluate different doses of BG-68501 in participants with various advanced-stage cancers, an…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study on the Effects of Drugs That Modulate the Endocannabinoid System on Spontaneous and Induced Contractility of the Human Detrusor Muscle
This document reports a clinical trial investigating endocannabinoid-system–modulating drugs and their effects on detrusor muscle contractil…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial [Phase 2]
Phase 2 BRIGHT trial combines immunotherapy with radiation therapy to potentially avoid bladder removal after shrinking muscle-invasive blad…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer [Phase 2]
This update summarizes a Phase 2 study of oral erdafitinib in patients with recurrent non-muscle invasive bladder cancer, including FGFR3-mu…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study assessing the combination of nivolumab, ipilimumab, and cabozantinib for various rare ge…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer [Phase 1]
Phase 1 study evaluating 68Ga-PSMA-PET/CT imaging in people with bladder cancer or skin cancer.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
This clinical trial update reports that recruitment is ongoing for a study comparing intravesical therapy and surgical options for bladder c…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors [Phase 1]
Phase 1 clinical trial update showing LY4052031 being studied in advanced or metastatic urothelial cancer and other solid tumors; the study …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
A clinical trial update describes en-bloc transurethral resection of bladder tumor (En-bloc TURBT) using a redesigned resectoscope device; t…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
A Mayo Clinic-sponsored study evaluates quality of life after bladder cancer treatment across stages 0 to IIIA and is currently active but n…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC [Phase 2]
Phase 2 clinical trial evaluating intravesical gemcitabine and docetaxel for high-risk, BCG-unresponsive non-muscle-invasive bladder cancer;…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors [NA]
The update describes a trial comparing Computed Tomography Urography (CTU) to Intravenous Urography (IVU) for patients at risk of urothelial…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial [Phase 2]
Phase 2 trial evaluating whether adding pembrolizumab to radiation therapy improves outcomes for non-muscle invasive bladder urothelial carc…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: ARID1A and/or KDM6A Mutation and CXCL13 Expression [Phase 2]
Phase 2 clinical trial update from MD Anderson investigating ARID1A and/or KDM6A mutation status and CXCL13 expression in urothelial cancers…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating modern immunotherapy for non-muscle invasive bladder cancer (urothelial carcinoma of the bladder) in BCG…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Measuring Surgical Recovery After Radical Cystectomy
A clinical trial sponsored by MD Anderson Cancer Center is recruiting to study how surgical recovery is measured after radical cystectomy fo…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Tumor Budding and T1 Substaging in Urothelial Bladder Cancer
A clinical trial update focusing on tumor budding and T1 sub-staging in urothelial bladder cancer; recruitment is not yet started.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer [Phase 3]
Phase 3 clinical trial update evaluating eribulin plus standard chemotherapy versus standard chemotherapy alone for metastatic urothelial ca…